The report provides a detailed analysis essential for establishing a Ferumoxytol production plant. It encompasses all critical aspects necessary for Ferumoxytol production, including the cost of Ferumoxytol production, Ferumoxytol plant cost, Ferumoxytol production costs, and the overall Ferumoxytol production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Ferumoxytol production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Ferumoxytol is an iron-based compound primarily used for the treatment of iron deficiency anaemia. It serves as a medication in the treatment of iron deficiency anaemia, particularly in patients with chronic kidney disease. It is commonly administered intravenously to quickly restore iron levels in patients who cannot tolerate oral iron supplements.
It works by replenishing iron levels in the body, which helps to improve the production of red blood cells and oxygen transport. It also finds application in medical imaging, as it can act as a contrast agent for magnetic resonance imaging (MRI), which helps to enhance the visibility of blood vessels and tissues. It is often used in research studies related to iron metabolism and the development of new therapies for anaemia.
The primary factor that drives the demand for Ferumoxytol is its application as an intravenous iron therapy for the treatment of iron deficiency anaemia, which boosts its market expansion. Its application as a drug in the treatment of anaemia, especially in patients with chronic kidney disease, strongly supports its demand in the pharmaceutical and healthcare industries. Its usage as a contrast agent in magnetic resonance imaging (MRI) to enhance the visibility of blood vessels and tissues also promotes its demand in the medical and diagnostics industries. Its involvement in research to study other conditions related to iron metabolism and in the development of new diagnostic techniques also adds to its demand in the pharmaceutical research industry.
Its demand as an important tool in both medical and scientific fields, due to its ability to deliver iron efficiently and safely, also strengthens its market expansion. Factors such as the availability and quality of raw materials, strict regulatory approvals, production complexity, and compliance with safety standards largely impact industrial Ferumoxytol procurement. Moreover, advancements in nanoparticle formulation technologies, reliable supplier networks, cold-chain logistics, and sustainability practices play an important role in shaping procurement strategies and overall market demand.
Raw Material for Ferumoxytol Production
According to the Ferumoxytol production plant project report, the major raw materials for Ferumoxytol production include Polyglucose Sorbitol Carboxymethyl Ether, Ferrous Chloride, and Ferric Chloride.
Production Process of Ferumoxytol
The extensive Ferumoxytol production cost report consists of the following industrial production process:
- Production via Chemical Synthesis: The production process of Ferumoxytol begins with the mixing of a solution of polyglucose sorbitol carboxymethyl ether (modified dextran) with ferrous chloride and ferric chloride. Then, the mixture is placed in an ice water bath under nitrogen bubbling. The reaction vessel is transferred into an alternating magnetic field (AMF) coil, where the temperature is gradually maintained between 0 and 2 degree Celsius. A slow addition of aqueous ammonia is made to the solution while mild agitation is applied. The AMF device is activated, and the output current is gradually increased, which allows the temperature to rise slowly from 0 degree Celsius to 80 degree Celsius over a period of time. Once the desired temperature is reached, it is maintained for two hours with air bubbling, which results in the formation of Ferumoxytol as the final product.
Ferumoxytol is a colloidal iron preparation that has no distinct odour and exists as an aqueous suspension, black to reddish-brown liquid. The molecular formula of the compound is Fe3H2O4, and its molecular mass is 233.54848 g/mol. The compound has a density of approximately 1.04 g/cm³. It is insoluble in water but forms a stable suspension in aqueous solutions for intravenous use. The pH of the compound remains between 6 and 8 in a solution. It does not have a defined melting or boiling point under standard conditions, as it is used in colloidal form and is generally administered via injection. Ferumoxytol may have some side effects, like dizziness, nausea, and hypotension, especially after administration. Protective measures, such as monitoring during infusion, are recommended due to the risk of allergic reactions.